Project HOPE Partners with Eli Lilly and Company to bring Non Communicable Disease Services to Johannesburg

 After a long wait and lots of hard work, I am excited to announce to you today that Project HOPE has secured a five year, up to $3.5 million US Dollar grant from Eli Lilly and Company to implement a non-communicable disease (NCD) project called the HOPE Centre in Zandspruit, Johannesburg,  South Africa.

The Eli Lilly NCD Partnership is a new $30 million, five-year commitment to address non-communicable diseases with Project HOPE and five other non-governmental organization (NGO) partners in four countries (South Africa, India, Brazil and Mexico) around the world. Eli Lilly is launching the partnership, which combines the company’s unique resources with the expertise of HOPE and other leading global health organisations, to identify new models of patient care that increase treatment access and improve outcomes for under served communities.

This is a very exciting time for Project HOPE, as together with Eli Lilly, we work together to find solutions to some of the world’s most pressing health problems related to chronic diseases. Non-communicable diseases in South Africa represent a major challenge to the country, in particular in areas like townships where already existing health services are either overstretched or non-existent.

Together with local community stakeholders, the City of Johannesburg, the University of Pretoria and Eli Lilly, Project HOPE will run the HOPE Centre project, based out of Emthonjeni Community Centre in the heart of Zandspruit which is a township on the outskirts of Johannesburg.

Thank you to all of you who have supported this initiative over the previous months. I cant wait to share with you the developments over the coming weeks.
 
In the mean time if you have any further questions or comments please feel free to contact me on slawson@projecthope.org


Thanks for reading!

Stefan

PS. Remember to "like" us on facebook to get regular shorter updates.  

0 comments:

Post a Comment